HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $278,532 | +40384.3% | 2,700 | -57.1% | 0.00% | -100.0% |
| Q1 2023 | $688 | -89.8% | 6,300 | -89.3% | 0.00% | -90.0% |
| Q4 2022 | $6,714 | -99.7% | 59,000 | +118.9% | 0.01% | +150.0% |
| Q2 2022 | $2,224,000 | -46.7% | 26,954 | -31.6% | 0.00% | -20.0% |
| Q1 2022 | $4,172,000 | -25.7% | 39,425 | -24.0% | 0.01% | -28.6% |
| Q4 2021 | $5,618,000 | +10.4% | 51,892 | +12.0% | 0.01% | +16.7% |
| Q3 2021 | $5,087,000 | +37.6% | 46,320 | +18.9% | 0.01% | +20.0% |
| Q2 2021 | $3,696,000 | -34.3% | 38,965 | -39.6% | 0.01% | -37.5% |
| Q1 2021 | $5,623,000 | -26.1% | 64,541 | -38.6% | 0.01% | -33.3% |
| Q4 2020 | $7,604,000 | +3.0% | 105,112 | +11.3% | 0.01% | -29.4% |
| Q3 2020 | $7,381,000 | +232.9% | 94,432 | +135.5% | 0.02% | +183.3% |
| Q2 2020 | $2,217,000 | +108.0% | 40,101 | +10.5% | 0.01% | +100.0% |
| Q1 2020 | $1,066,000 | -52.6% | 36,300 | -41.8% | 0.00% | -50.0% |
| Q4 2019 | $2,249,000 | +2.3% | 62,416 | -21.8% | 0.01% | -14.3% |
| Q3 2019 | $2,199,000 | -27.1% | 79,828 | -36.3% | 0.01% | -22.2% |
| Q2 2019 | $3,017,000 | – | 125,378 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |